Wednesday, March 05, 2025 | 02:42 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Unichem Laboratories receives ANDA approval for Extended Phenytoin Sodium Capsules

Image

Capital Market

From USFDA

Unichem Laboratories has received ANDA approval for its Extended Phenytoin Sodium Capsules USP, 100 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Dilantin (Phenytoin Sodium) Capsules, 100 mg, of Viatris Specialty LLC.

Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. The product will be commercialized from Unichem's Ghaziabad Plant.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 14 2022 | 10:31 AM IST

Explore News